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I. Introduction 
Breast cancer is one of the most prevalent forms of cancer 
in women and is a great source of concern. Although huge amounts 
of research have been done about breast cancer, there is still 
no consensus on what causes it or how to effectively treat it. 
To date, the only way to reduce the risk of breast cancer is 
to alter the amount of dietary fat consumed. studies on this 
are inconclusive, but it is generally thought that reducing 
the amount of certain fats will reduce the risk of breast cancer. 
The purpose of this study will be to study the effects of 
different dietary fats on daily tumor growth and time to tumor. 
It is presumed that diets that contain stearic acid, as their 
fatty acid, will have a slower daily growth and a longer time 
to tumor. 
II. Review of Related Literature 
In 1974 saturated fat, in terms of nutrient labeling, was 
defined as the sum of lauric, myristic, palmitic and stearic 
acids (16). This definition was adequate for that time because 
nutrient information was voluntary except for when a special 
claim was made. In 1990 the Nutrition Labeling and Education 
Act (NLEA) kept the same definition of a saturated fat but 
required all foods to display nutritional information (16). 
The 1974 definition of a saturated fat is not adequate for this 
day and age because not all saturated fats behave the same, 
and the nutritional information can be misleading. Stearic 
acid is one such fatty acid that does not behave in the same 
way as other fatty acids. When stearic acid is the major source 
of fatty acids in an animals diet, there is a decrease in tumor 
incidence and an increase in time to tumor as compared to animals 
whose fatty acids are obtained from other sources. Bennett 
showed that mice fed a high fat diet, in which stearic acid 
is the primary fatty acid, have a longer time to initial 
development of spontaneous mammary adenocarcinomas than do mice 
fed a low fat diet (1). Tinsley also showed that stearic acid 
was associated with decreased tumor incidence and increased 
time to tumor (16). Stearic acid is also unique from other 
saturated fatty acids in that it does not raise cholesterol 
levels (9). In fact, Bonanome has shown that stearic acid 
reduces cholesterol levels by as much as 14 percent as compared 
to other saturated fats (2). This only happens when stearic 
is ingested alone and therein lies the problem. Most foods 
that contain stearic acid also contain the saturated fatty acids 
that are most people try to avoid. To combat the intake of 
saturated fats, people usually decrease their total intake of 
fats. This is not always a good thing. When a person reduces 
their fat intake greatly, they might be increasing their risk 
of other complications. In order to combat this, and breast 
cancer, effectively, a procedure must be devised where a person 
can increase their stearic acid intake without substantially 
increasing or decreasing their overall,non-stearic, saturated 
fat intake. 
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III. Materials and Methods 
Strain A/St mice were maintained in our laboratory by 
brother sister inbreeding. The mice were kept in a controlled 
enviroment of 21-24 C and a 12 h light: 12 h dark cycle and 
fed a 4.5% fat stock diet of Purina Lab Chow (Ralston Purina, 
st. Louis, MOl and water ad libitum upon weaning. Originally, 
10mg portions were cut from a 400 to 500mg perpetuated mouse 
tumor. These portions were then surgically implanted into the 
right number 4 mammary gland. The incision was then closed 
by two surgical steel staples and an ear tag was placed in their 
left ear. The mice were then sacrificed two weeks later, and 
the resulting tumors were removed and weighed. After the first 
attempt at this surgery, the procedure was altered slightly. 
Instead of implanting 10mg portions, a set of 50mg portions 
and a set of 20mg portions were implanted in the right number 
4 mammary glands of mice. These mice were then sacrificed two 
weeks later, and the tumors were removed and weighed. 
After receiving no clear data, a new approach was tried. 
The mice were randomly separated into four groups of five. 
These groups were then feed one of the following diets after 
they were injected with a tumor suspension: SF containing 15% 
safflower oil, SF-1 containing 1% safflower oil, PA containing 
or SA-1 containing 14% stearic acid and 1% safflower oil. 
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A mouse with a perpetuated tumor of about 500mg was sacrificed 
and the tumor was placed in a RPM I solution. The tumor was 
masserated until the solution was homogenous. The solution 
was then filtered through nylon mesh. This allows only single 
cells pass through. A 1:10 single cell suspension to trypan 
blue solution was made and counted on the hemocytometer. The 
resulting solution was diluted so that an injection of .2 ml 
of solution contained 600,000 single cancer cells. Twenty mice 
that were two months old were injected with .2 ml of the cell 
suspension. The mice were checked daily, and when the resulting 
tumor reached the size of approximately 1-2mm across, or about 
150-200mg, they were removed and weighed. 
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IV. Results 
The results from the original 10 mg implants showed that 
there was nodirect link in the size of tumor implanted and 
resulting size of the final tumor. Final weights ranged from 
140 mg to 780 mg. This was too broad of a range to draw any 
conclusive results. 
The results from the altered procedure also showed that 
no link can be drawn from the tumor implant size to the final 
tumor size. The tumors removed from the two mice that had 
approximately 50 mg implants different by 1383 mg and, the tumors 
from the 20 mg implants were different by 2786 mg (Table 1). 
Both trials showed no consistency in the size of the tumor 
implant and the time amount of concurrent growth. An interesting 
phenomenon was observed in the two mice that received the 50 
mg implants. When the tumors were removed, they had a hard 
capsule covering almost like that of a cyst. When the capsule 
was pierced and removed, there was a build up of fluid observed 
within the capsule. It was almost as though the mice's bodies 
had responded to the large 50 mg implants as a foreign object 
rather than a tumor. 
After all the tumors were removed from the mice with the 
600,000 cell injection, the mg of growth per day were calculated 
(Table 3). The averages of daily growth for each diet were 
7 
Table 1: WEIGHTS OF TUMORS TWO WEEKS AFTER IMPLANTS 
Implant weight Age of Mouse Tumor weight 
(mg) (months) (mg) 
18 7 4795 
53 7 4287 
20 5 2009 
47 6 2904 
TABLE 2: WEIGHTS AND DAYS OF REMOVAL OF TUMOR INJECTIONS 
Diet 
SF SF-1 SA-1 PA 
Days 
18 110mg 299mg 206mg 95mg 
21 89mg 110mg 202mg 237mg 
23 225mg 105mg 54mg 
25 100mg 128mg 
26 136mg 147mg 
29 137mg 194mg 
30 161mg 184mg 
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then found (Table 3). The averages were very different from 
the expected. The SA-l, or stearic acid rich, diet was found 
to have the highest average daily growth. There was also a 
different result than was expected in the unsaturated fatty 
acid diets. The diet that held only the minimum daily 
requirements of fatty aCids had a higher average growth rate 
than the high fat diet. 
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Table 3: TUMOR GROWTH PER DAY AND AVERAGES IN mg 
Tumor 1 Tumor 2 Tumor 3 Tumor 4 Tumor 5 Average 
Diets 
, 
SF 6.11 4.24 4.00 5.37 4.93! 
SF-1 5.24 9.78 5.12 4.72 6.69 I 6.31 I 
SA-1 16.60 9.78 12.48 5.23 5.65 10.26, 
L. PA 5.28 11 .29 7.17 2.35 6.1 3 6.44
1 
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V. Discussion 
According to the existing literature, stearic acid causes 
the least detrimental effects of all saturated fatty acids. 
This is not what we found, and in fact, we found the opposite 
to be true in our experiment. If this type of experiment was 
to be repeated, there should be more than 5 mice in each of 
the groups, and the entire experiment should be repeated more 
than once so that consistency could be proven. It has been 
shown many times in results from different research labs that 
stearic acid has different effects than other saturated fatty 
acids. According to our results stearic acid is no different 
from other fatty acids in its effects on tumor growth. 
Although we were trying to find a relationship between 
different dietary fats and daily growth of tumors, no data was 
found that showed us that one type of fatty acid is better for 
a person over another. Our tumor implanting technique was not 
successful at producing reproducible results. This inconsistent 
data may be the result of many avenues of error. First of all, 
we found that the size of the implant is crucial to its growth. 
If too big a piece of a tumor is implanted, the body acts 
strangely to it. The body encases the tumor in a cyst-like 
capsule and this probably impedes the true growth of the tumor. 
Second, we didn't use enough test subjects to get a very accurate 
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reading. If more test subjects were used, there might have 
been consistent results for the tumor growth per day. Also 
if we had put tumor implanted mice on the different fat diets, 
this might have gave us better results than the stock diets. 
For future reference, large amounts of test subjects and tumor 
implants under 50 mg should be used for this type of 
experimentation. We did find one interesting thing about the 
whole procedure. The tumors in the older mice, ones that were 
four months old, seemed to grow faster than the tumors in the 
younger mice, ones of two months old. The final tumor size 
in each of the age groups were about the same no matter what 
size of tumor was implanted. This could be an area that would 
be a source of good information. 
Even after changing our procedure, we still came out the 
experiment without any data that specifically showed that one 
fatty acid is better than any other. The average tumor growth 
per day was far from what we expected. If the results had gone 
as expected, the PA diet would have yielded the highest average 
growth per day. As it turned out, PA yielded the second highest 
growth per day behind the SA-1 diet which should have yielded 
the lowest growth per day out of all of the diets. Not only 
were the saturated fats not as expected, but the results of 
the unsaturated diets was not as expected either. The high 
percentage saturated fat diet resulted in a lower daily growth 
than the diet that contained only the minimum daily requirements 
of fat. This data may not give consistent results because the 
a small group of each diet was used. This leaves a lot of room 
1 3 
for deviation from the normal. 
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